Clinical Trials Directory

Trials / Unknown

UnknownNCT03976583

Remineralization Potential of Pearl Powder Compared to CPP-ACP on Enamel White Spot Lesions

Remineralization Potential of Pearl Powder Compared to CPP-ACP on Enamel White Spot Lesions (Randomized Controlled Trial)

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
12 Years – 25 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate the remineralization potential of pearl powder on early ('white spot') lesions in enamel in orthodontic patients compared to casein phosphopeptide-amorphous calcium phosphate.

Detailed description

The aim of this study is to evaluate the remineralization potential of pearl powder on early ('white spot') lesions in enamel in orthodontic patients compared to casein phosphopeptide-amorphous calcium phosphate. The remineralisation potential will be assessed both visually and by standardised photographic image analysis. the follow up will be up to 12 months.

Conditions

Interventions

TypeNameDescription
DRUGCpp-AcpRemineralising agent
OTHERPearl powderNatural product

Timeline

Start date
2019-09-01
Primary completion
2020-09-01
Completion
2021-09-01
First posted
2019-06-06
Last updated
2019-06-07

Source: ClinicalTrials.gov record NCT03976583. Inclusion in this directory is not an endorsement.

Remineralization Potential of Pearl Powder Compared to CPP-ACP on Enamel White Spot Lesions (NCT03976583) · Clinical Trials Directory